Others notice a distinct reduction in hunger
Soueid J, Hamze Z, Bedran J, Chahrour M, Boustany RM (2023) A novel autism-associated UBLCP1 mutation impacts proteasome regulation/activity
Weight loss can be a byproduct of taking Ozempic, whereas Wegovy is a slightly higher dose of semaglutide specifically geared toward people who are obese or overweight but may have type 2 diabetes
Although it is FDA-approved for managing type 2 diabetes, it is often used off-label for weight loss in individuals who meet certain criteria, such as having a body mass index (BMI) of 30 or higher, or 27 and above with weight-related health conditions
Individual results vary enormously
doi: 10.2337/dc17-2510 4 ArtasensiAPedrettiAVistoliGFumagalliL